Last reviewed · How we verify
Reduced Nicotine Content Cigars
Reduced nicotine content cigars lower the addictive nicotine dose delivered per cigar to decrease dependence and tobacco-related harm.
Reduced nicotine content cigars lower the addictive nicotine dose delivered per cigar to decrease dependence and tobacco-related harm. Used for Nicotine dependence reduction in cigar users, Tobacco harm reduction.
At a glance
| Generic name | Reduced Nicotine Content Cigars |
|---|---|
| Also known as | VLNFLC |
| Sponsor | Ohio State University Comprehensive Cancer Center |
| Modality | Small molecule |
| Therapeutic area | Tobacco Harm Reduction / Addiction Medicine |
| Phase | FDA-approved |
Mechanism of action
By reducing nicotine concentration in cigars, this product aims to decrease nicotine addiction potential while allowing continued use, similar to nicotine reduction strategies in cigarettes. The lower nicotine content may reduce cardiovascular and neurological effects of nicotine while maintaining behavioral/sensory aspects of cigar use. This is a harm-reduction rather than cessation-focused approach.
Approved indications
- Nicotine dependence reduction in cigar users
- Tobacco harm reduction
Common side effects
- Withdrawal symptoms (if used as cessation aid)
- Continued tobacco-related health risks
Key clinical trials
- Addiction Potential of Very Low Nicotine Filtered Little Cigars (PHASE4)
- Reduced Nicotine Content Cigarettes and Tobacco Switching Behaviors (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: